Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2014
03/11/2014US8669345 Nogo receptor antagonists
03/11/2014US8669092 Urocortin-III and uses thereof
03/11/2014US8669046 Reagents and methods for detecting influenza virus proteins
03/11/2014US8668910 Antibodies that specifically bind to the EphA2 receptor
03/11/2014US8668909 Anti MIF antibodies
03/11/2014CA2595276C Anti-interferon gamma antibodies and methods of use thereof
03/11/2014CA2567449C Antibodies and related molecules that bind to psca proteins
03/11/2014CA2531684C Binding molecules against sars-coronavirus and uses thereof
03/11/2014CA2495198C Novel lipases and uses thereof
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/06/2014WO2014036495A2 Diagnostic assays and kits for detection of folate receptor 1
03/06/2014WO2014036385A1 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1)
03/06/2014WO2014036357A1 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/06/2014WO2014036076A1 Anti-prolactin receptor antibody formulations
03/06/2014WO2014036071A1 Antibody and protein formulations
03/06/2014WO2014035828A2 Inhibition of axl signaling in anti-metastatic therapy
03/06/2014WO2014035361A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF
03/06/2014WO2014034700A1 CELL PROLIFERATION REGULATION COMPOSITION CONTAINING PEPTIDE COMPRISING PARTIAL AMINO ACID SEQUENCE FOR BBF2H7 (BBF2 human homologue on chromosome7) OR ANTIBODY CAPABLE OF BINDING TO SAID PEPTIDE
03/06/2014WO2014034457A1 Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
03/06/2014WO2014034127A1 Binding/neutralizing human monoclonal antibodies against botulinum neurotoxin type b
03/06/2014WO2014033327A1 Antibodies directed against icos for treating graft-versus-host disease
03/06/2014WO2014033313A1 Protective anti-etec antibody
03/06/2014WO2014033266A1 Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
03/06/2014WO2014033252A1 Method for producing antibody molecules having inter-species, intra-target cross-reactivity
03/06/2014WO2014033130A1 Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
03/06/2014WO2014033126A1 Methods for purification of antibodies using aliphatic alcohols
03/06/2014WO2014033074A1 Blood brain barrier shuttle
03/06/2014WO2014026033A9 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
03/06/2014WO2014011955A3 Il-1 binding proteins
03/06/2014WO2014011853A3 Igy from norovirus p particles and their derivatives
03/06/2014WO2013186777A3 Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
03/06/2014WO2013167681A8 CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST Αβ OLIGOMERS
03/06/2014WO2013106485A3 Ultralong complementarity determining regions and uses thereof
03/06/2014WO2013061163A3 Tdp-43 specific binding molecules
03/06/2014US20140068795 Methods for Genetic Diversification in Gene Conversion Active Cells
03/06/2014US20140066604 Molecular marker cuedc2 protein for prognostic determination of breast cancer endocrinology therapy
03/06/2014US20140066603 Anti-ron antibodies
03/06/2014US20140066602 Peptides for treatment and diagnosis of bone diseases
03/06/2014US20140066601 Alphabody libraries and methods for producing the same
03/06/2014US20140066600 Novel lowered affinity antibodies and uses therefor
03/06/2014US20140066599 Hetero-Dimeric Immunoglobulins
03/06/2014US20140066598 Modified Amino Acids
03/06/2014US20140066384 Novel genes and proteins that home to developing microvessels
03/06/2014US20140066378 Multivalent Heteromultimer Scaffold Design and Constructs
03/06/2014US20140065724 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
03/06/2014US20140065723 Enrichment and purification of infectious prion protein
03/06/2014US20140065707 Antibodies against human angiopoietin 2
03/06/2014US20140065690 Avian Transgenesis and Exogenous Proteins
03/06/2014US20140065674 Antibody molecules which bind il-17a and il-17f
03/06/2014US20140065645 Polypeptide linker and method of analyzing target material using the same
03/06/2014US20140065643 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
03/06/2014US20140065599 Novel polymavirus associated with diarrhea in children
03/06/2014US20140065171 Site-Specific Labeling Methods and Molecules Produced Thereby
03/06/2014US20140065168 Anti-kit antibodies and uses thereof
03/06/2014US20140065167 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM
03/06/2014US20140065166 Neutralizing Antiboides to Nipah and Hendra Virus
03/06/2014US20140065165 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
03/06/2014US20140065163 Antibody with specificity for gm-csf (ii)
03/06/2014US20140065160 Combination therapy
03/06/2014US20140065158 Anti-prolactin receptor antibody formulations
03/06/2014US20140065156 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
03/06/2014US20140065155 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
03/06/2014US20140065154 Tlr3 binding agents
03/06/2014US20140065152 Novel epitope for switching to th1 cell and use thereof
03/06/2014US20140065151 Antibodies against human angiopoietin 2
03/06/2014US20140065148 Treatment methods using antibodies to aminophospholipids
03/06/2014US20140065146 Anti-siglec-15 antibody
03/06/2014US20140065144 Use of il-20 antagonists for promoting bone fracture healing
03/06/2014US20140065143 Inhibition of AXL Signaling in Anti-Metastatic Therapy
03/06/2014US20140065142 Multivalent and Monovalent Multispecific Complexes and Their Uses
03/06/2014US20140065138 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
03/06/2014US20140065137 Humanized anti-factor d antibodies and uses thereof
03/06/2014US20140065135 Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunity
03/06/2014US20140065097 Immunotherapy
03/06/2014US20140065064 Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor
03/06/2014US20140065063 Therapeutic use of anti-cs1 antibodies
03/05/2014EP2703486A1 Anti-b7-h3 antibody
03/05/2014EP2703485A1 Method for selecting plasma cells and plasmablasts, method for producing target antigen-specific antibody, and new monoclonal antibody
03/05/2014EP2703483A1 PCSK9 peptide vaccine
03/05/2014EP2703415A1 Novel compositions and methods for treating IgE-mediated disorders
03/05/2014EP2703414A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin
03/05/2014EP2703011A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
03/05/2014EP2703009A1 Combination treatments involving antibodies to human PCSK9
03/05/2014EP2703008A1 Human antibodies to PCSK9 for use in methods of treating particular groups of subjects
03/05/2014EP2703007A1 Antibodies with decreased deamidation profiles
03/05/2014EP2702412A1 Anti-human receptor-type protein tyrosine phosphatase antibody
03/05/2014EP2702164A1 A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
03/05/2014EP2702078A2 Anti-cd40 antibodies and methods of use
03/05/2014EP2702077A2 Methods for controlling the galactosylation profile of recombinantly-expressed proteins
03/05/2014EP2702076A1 Ip-10 antibody dosage escalation regimens
03/05/2014EP2702075A1 Neutralizing antibodies to nipah and hendra virus
03/05/2014EP2702074A1 Novel immunoconjugates
03/05/2014EP2702066A2 Selective anti-hla antibody removal device and methods of production and use thereof
03/05/2014EP2701741A1 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
03/05/2014CN103620405A Comprehensive monoclonal antibody generation
03/05/2014CN103620049A Hybrid polymerases having the ability to produce long amplicons
03/05/2014CN103620033A SEMA5B peptides and vaccines including the same
03/05/2014CN103620032A Express humanization of antibodies
03/05/2014CN103620031A Amino acid sequence presenting fusion polypeptide and its use
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1494